WallStSmart
THAR

Tharimmune Inc.

NASDAQ: THAR · HEALTHCARE · BIOTECHNOLOGY

$3.23
+3.53% today

Updated 2026-04-30

Market cap
$177.09M
P/E ratio
P/S ratio
EPS (TTM)
$-3.68
Dividend yield
52W range
$1 – $9
Volume
0.6M

Tharimmune Inc. (THAR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+86.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-8.8%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-8.8%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-12$-0.34$3.30$3.01-8.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$-0.34
2025-06-30$0.00$-0.64
2025-03-31$-0.99
2024-12-31$-2.14
2024-09-30$-2.45
2024-06-30$-2.42
2024-03-31$-2.88
2023-12-31$-1.25$-0.71+43.2%
2023-09-30$-0.06$-0.11-83.3%
2023-06-30$-0.16$-4.00-2400.0%
2023-03-31$-0.23$-5.75-2400.0%
2022-12-31$-0.15

Frequently asked questions

Has Tharimmune Inc. beaten earnings estimates?
Tharimmune Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports.
How does THAR stock react to earnings?
THAR stock has moved an average of -8.8% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.